Teva Pharmaceutical Industries PE Ratio 2006-2018 | TEVA

Current and historical PE ratio for Teva Pharmaceutical Industries (TEVA) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Teva Pharmaceutical Industries (TEVA) as of March 31, 2018 is 6.15.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $22.385B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $59.560B 10.48
Mylan (MYL) United Kingdom $18.748B 7.92
Dr Reddy's Laboratories (RDY) India $4.948B 29.55
Supernus Pharmaceuticals (SUPN) United States $2.774B 34.77
Akorn (AKRX) United States $2.097B 10.40
AxoGen (AXGN) United States $1.897B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.795B 3.03
Assembly Biosciences (ASMB) United States $0.895B 0.00
Homology Medicines (FIXX) United States $0.803B 0.00
CymaBay Therapeutics (CBAY) United States $0.790B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.765B 71.39
Adamas Pharmaceuticals (ADMS) United States $0.735B 0.00
Voyager Therapeutics (VYGR) United States $0.643B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.606B 0.00
Corium (CORI) United States $0.293B 0.00
Teligent (TLGT) United States $0.218B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.137B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Versartis (VSAR) United States $0.076B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.070B 0.00
Aevi Genomic Medicine (GNMX) United States $0.054B 0.00
Evoke Pharma (EVOK) United States $0.044B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00
Acasti Pharma (ACST) Canada $0.014B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00